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IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells
Eleanor Clancy-Thompson, Lestat Ali, Patrick T. Bruck, Mark A. Exley, Richard S. Blumberg, Glenn Dranoff, Michael Dougan, and Stephanie K. Dougan IAP antagonists inhibit tumor growth in vivo primarily through augmentation of antitumor immunity. IAP antagonists were found to augment iNKT cell-mediated antitumor immunity in mice and were useful in expanding human IFNg-producing iNKT cells ex vivo.
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High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model Sarah A. Richman, Selene Nunez-Cruz, Babak Moghimi, Lucy Z. Li, Zachary T. Gershenson, Zissimos Mourelatos, David M. Barrett, Stephan A. Grupp, and Michael C. Milone GD2 is a ganglioside on neuroblastomas and is expressed in certain brain regions. Severe and fatal neurotoxicity resulted from the use of T cells bearing an enhanced chimeric antigen receptor to GD2, indicating a narrow immunotherapeutic window. 
